ConductScience.org, home

Gene · 9232

NIH grants1,474

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePTTG1 papersNewest fiscal year
P50CA097186The Pacific Northwest Prostate Cancer SPORE22025
P50CA116201Mayo Clinic Breast Cancer SPORE22025
R01CA148761Therapeutic Targeting of Breast Cancer Tumor Initiating Cells22025
R01CA197780Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer22025
R01DK113998Mechanisms for GH action on epithelial cells22025
R35CA253027Deciphering the physiological role and interplay between ubiquitination and phosphorylation pathways to guide targeted cancer therapies22025
R35GM147525Chromosome dynamics and organizations necessary for faithful chromosome segregation22025
T32CA009056Tumor Cell Biology Training Program22025
T32CA009110Training in Areas Fundamental to Cancer Research22025
T90DE021990Comprehensive Training Program in Oral Biology22025
U54AI170660Center for Structural Biology of HIV RNA22025
U54CA1630682/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership22025
U54GM104938Oklahoma Shared Clinical and Translational Resources22025
UL1TR001857University of Pittsburgh Clinical and Translational Science Institute22025
UL1TR001863Yale Clinical and Translational Science Award22025
ZIABC008752Thyroid Hormone Nuclear Receptors in Health and Disease22025
ZIABC010411Initiation of DNA Replication in Mammalian Cells22025
ZIADE000704Clinical and Mechanistic Investigations of Salivary Gland Dysfunction22025
ZIAES101074Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease22025
F30OD031914MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/9232/grants?page=3